A Phase 1, Randomized, Double-Blind, Multiple Dose, Multi-Center Study to Compare the Safety of ASP2151 to Valacylcovir and Placebo in Healthy Male and Female Subjects.

Trial Profile

A Phase 1, Randomized, Double-Blind, Multiple Dose, Multi-Center Study to Compare the Safety of ASP2151 to Valacylcovir and Placebo in Healthy Male and Female Subjects.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 27 Feb 2013

At a glance

  • Drugs Amenamevir; Valaciclovir
  • Indications Cytomegalovirus infections; Herpes simplex virus infections; Herpes zoster; Herpesvirus infections
  • Focus Adverse reactions
  • Most Recent Events

    • 10 Jun 2010 Actual patient number (442) added as reported by ClinicalTrials.gov.
    • 10 Jun 2010 Status changed from suspended to discontinued as reported by ClinicalTrials.gov.
    • 27 May 2009 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top